{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:47:11Z","timestamp":1793908031801,"version":"4.8.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0103000"],"award-info":[{"award-number":["2018YFE0103000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have worse clinical outcomes than those with sinus rhythm (SR). We aim to investigate whether maintaining SR in patients with HFpEF through a strategy such as AF ablation would improve outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This is a cohort study that analysed 1034 patients (median age 69 [63\u201376] years, 46.2% [478\/1034] female) with HFpEF and AF. Of these, 392 patients who underwent first-time AF ablation were assigned to the ablation group, and the remaining 642 patients, who received only medical therapy, were assigned to the no ablation group. The primary endpoint was a composite of all-cause death or rehospitalization for worsening heart failure. After a median follow-up of 39 months, the cumulative incidence of the primary endpoint was significantly lower in the ablation group compared to the no ablation group (adjusted hazard ratio [HR], 0.55 [95% CI, 0.37\u20130.82], P = 0.003) in the propensity score-matched model. Secondary endpoint analysis showed that the benefit of AF ablation was mainly driven by a reduction in rehospitalization for worsening heart failure (adjusted HR, 0.52 [95% CI, 0.34\u20130.80], P = 0.003). Patients in the ablation group showed a 33% relative decrease in atrial tachycardia\/AF recurrence compared to the no ablation group (adjusted HR, 0.67 [95% CI, 0.54\u20130.84], P &amp;lt; 0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Among patients with HFpEF and AF, the strategy of AF ablation to maintain SR was associated with a lower risk of the composite outcome of all-cause death or rehospitalization for worsening heart failure.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad363","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T12:12:45Z","timestamp":1702642365000},"source":"Crossref","is-referenced-by-count":42,"title":["Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6096-7956","authenticated-orcid":false,"given":"Zhonglei","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Qingdao University , Qingdao , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-0486","authenticated-orcid":false,"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-7332","authenticated-orcid":false,"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , Fenglin Road 180, Xuhui District , 200032 Shanghai, China"},{"name":"Institutes of Biomedical Sciences, Fudan University , Yixueyuan Road 138, Xuhui District, 200032 Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"2024013106510037400_euad363-B1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024013106510037400_euad363-B2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/CJ.2020.0023","article-title":"Coding proposal on phenotyping heart failure with preserved ejection fraction: a practical tool for facilitating etiology-oriented therapy","volume":"27","author":"Ge","year":"2020","journal-title":"Cardiol J"},{"key":"2024013106510037400_euad363-B3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024013106510037400_euad363-B4","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B5","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024013106510037400_euad363-B6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","article-title":"Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"7","author":"Zakeri","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2024013106510037400_euad363-B8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/ejhf.930","article-title":"Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction","volume":"19","author":"Kaye","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2024013106510037400_euad363-B9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchf.2016.10.005","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: association with exercise capacity, left ventricular filling pressures, natriuretic peptides, and left atrial volume","volume":"5","author":"Lam","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2024013106510037400_euad363-B10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2018.05.005","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: the TOPCAT trial","volume":"6","author":"Cikes","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2024013106510037400_euad363-B11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad095","article-title":"Atrial fibrillation can adversely impact heart failure with preserved ejection fraction by its association with heart failure progression and mortality: a post-hoc propensity score-matched analysis of the TOPCAT Americas trial","volume":"25","author":"Saksena","year":"2023","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B12","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024013106510037400_euad363-B14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.hrthm.2017.12.001","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"},{"key":"2024013106510037400_euad363-B15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2020.09.018","article-title":"Comparison of outcomes after ablation of atrial fibrillation in patients with heart failure with preserved versus reduced ejection fraction","volume":"136","author":"Aldaas","year":"2020","journal-title":"Am J Cardiol"},{"key":"2024013106510037400_euad363-B16","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/europace\/euaa420","article-title":"Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide","volume":"23","author":"Yamauchi","year":"2021","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hroo.2022.06.012","article-title":"Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation","volume":"3","author":"Krishnamurthy","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"2024013106510037400_euad363-B18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/europace\/euab201","article-title":"Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction","volume":"24","author":"Fujimoto","year":"2022","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B19","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2013.07.020","article-title":"Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction","volume":"62","author":"Machino-Ohtsuka","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024013106510037400_euad363-B20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/europace\/euaa101","article-title":"Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients","volume":"22","author":"Rattka","year":"2020","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ejhf.2122","article-title":"A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF","volume":"23","author":"Sugumar","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2024013106510037400_euad363-B22","doi-asserted-by":"crossref","first-page":"e009281","DOI":"10.1161\/CIRCHEARTFAILURE.121.009281","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Zylla","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2024013106510037400_euad363-B23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B24","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/ejhf.2604","article-title":"Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry","volume":"24","author":"von Olshausen","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2024013106510037400_euad363-B26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/europace\/euac108","article-title":"Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study","volume":"25","author":"Shiraishi","year":"2023","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/jce.14369","article-title":"Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction","volume":"31","author":"Fukui","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024013106510037400_euad363-B28","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1111\/jce.15200","article-title":"Catheter ablation for atrial fibrillation in HFpEF patients\u2014a propensity-score-matched analysis","volume":"32","author":"Rattka","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024013106510037400_euad363-B29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2021.01.012","article-title":"A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: the RAFT-AF trial rationale and design","volume":"234","author":"Parkash","year":"2021","journal-title":"Am Heart J"},{"key":"2024013106510037400_euad363-B30","volume-title":"Catheter Ablation of Atrial Fibrillation","author":"Yamane","year":"2018"},{"key":"2024013106510037400_euad363-B31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.athoracsur.2009.05.046","article-title":"A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set","volume":"88","author":"Edgerton","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2024013106510037400_euad363-B32","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.hrthm.2009.09.011","article-title":"Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the \u201cDallas\u201d lesion set","volume":"6","author":"Edgerton","year":"2009","journal-title":"Heart Rhythm"},{"key":"2024013106510037400_euad363-B33","first-page":"98","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2014","volume":"42","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2014","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2024013106510037400_euad363-B34","first-page":"760","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2018","volume":"46","author":"Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association","year":"2018","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2024013106510037400_euad363-B35","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2024013106510037400_euad363-B36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024013106510037400_euad363-B37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2024013106510037400_euad363-B38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.2019.21558","article-title":"Using propensity score methods to create target populations in observational clinical research","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"2024013106510037400_euad363-B39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024013106510037400_euad363-B40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/bimj.201800274","article-title":"On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: the Fine\u2013Gray model revisited","volume":"62","author":"Putter","year":"2020","journal-title":"Biom J"},{"key":"2024013106510037400_euad363-B41","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/sim.3177","article-title":"How should variable selection be performed with multiply imputed data?","volume":"27","author":"Wood","year":"2008","journal-title":"Stat Med"},{"key":"2024013106510037400_euad363-B42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"2024013106510037400_euad363-B43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"2024013106510037400_euad363-B44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/europace\/euv215","article-title":"Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter","volume":"18","author":"Huang","year":"2016","journal-title":"Europace"},{"key":"2024013106510037400_euad363-B45","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.hrthm.2017.04.042","article-title":"Risk model for predicting complications in patients undergoing atrial fibrillation ablation","volume":"14","author":"Padala","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024013106510037400_euad363-B46","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.hrthm.2014.07.017","article-title":"Risk predictors of stroke and mortality after ablation for atrial fibrillation: the California experience 2005\u20132009","volume":"11","author":"Srivatsa","year":"2014","journal-title":"Heart Rhythm"},{"key":"2024013106510037400_euad363-B47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/EDE.0000000000000091","article-title":"Healthy volunteer effect and cardiovascular risk","volume":"25","author":"Leening","year":"2014","journal-title":"Epidemiology"},{"key":"2024013106510037400_euad363-B48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2024013106510037400_euad363-B49","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/eurheartj\/ehz284","article-title":"Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation","volume":"40","author":"Packer","year":"2019","journal-title":"Eur Heart J"},{"key":"2024013106510037400_euad363-B50","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2024013106510037400_euad363-B51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2024013106510037400_euad363-B52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.hrthm.2018.09.016","article-title":"Reverse left ventricular structural remodeling after catheter ablation of atrial fibrillation in patients with preserved left ventricular function: insights from cardiovascular magnetic resonance native T1 mapping","volume":"16","author":"Kowallick","year":"2019","journal-title":"Heart Rhythm"},{"key":"2024013106510037400_euad363-B53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12574-018-0399-z","article-title":"Improvement of left ventricular function after successful radiofrequency catheter ablation in persistent atrial fibrillation with preserved left ventricular ejection fraction: a comprehensive echocardiographic assessment using two-dimensional speckle tracking analysis","volume":"17","author":"Nagai","year":"2019","journal-title":"J Echocardiogr"},{"key":"2024013106510037400_euad363-B54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCEP.108.838748","article-title":"Long-term improvement in left ventricular strain after successful catheter ablation for atrial fibrillation in patients with preserved left ventricular systolic function","volume":"2","author":"Tops","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024013106510037400_euad363-B55","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCEP.110.960690","article-title":"Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function","volume":"4","author":"Cha","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024013106510037400_euad363-B56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jchf.2023.01.008","article-title":"Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial","volume":"11","author":"Chieng","year":"2023","journal-title":"JACC Heart Fail"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euad363\/54459491\/euad363.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/1\/euad363\/56323939\/euad363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/1\/euad363\/56323939\/euad363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T06:51:44Z","timestamp":1706683904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad363\/7473451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad363","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,12,14]]},"article-number":"euad363"}}